# A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

> **NCT07553299** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Verdiva Bio Dev Limited** · enrollment: 120 (estimated)

## Conditions studied

- Obesity
- Overweight
- Weight Maintenance

## Interventions

- **DRUG:** VRB-101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07553299
- **Lead sponsor:** Verdiva Bio Dev Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07553299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07553299, "A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07553299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*